Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
Women'S Health (London, England)|July 28, 2011
Low-molecular-weight heparin in women with repeated implantation failureCorrado Lodigiani, Pierpaolo Di Micco, Paola Ferrazzi, et al.
The Lancet. Haematology|December 16, 2017
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trialMoshe Mittelman, Uwe Platzbecker, Boris Afanasyev, et al.
Cell Death & Disease|April 7, 2017
p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restrictionShrey Kohli, Juliane Hoffmann, Franziska Lochmann, et al.
The New England Journal of Medicine|March 31, 2020
Apixaban for the Treatment of Venous Thromboembolism Associated with CancerGiancarlo Agnelli, Cecilia Becattini, Guy Meyer, et al.
Thrombosis and Haemostasis|August 14, 2018
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio StudyGiancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, et al.
The Lancet. Haematology|August 30, 2016
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE studyMarjolein P A Brekelmans, Walter Ageno, Ludo F Beenen, et al.
Blood|September 4, 2016
Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblastsShrey Kohli, Satish Ranjan, Juliane Hoffmann, et al.
The New England Journal of Medicine|December 7, 2010
Oral rivaroxaban for symptomatic venous thromboembolism, Rupert Bauersachs, Scott D Berkowitz, et al.
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
European Journal of Haematology|February 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS OnsetHazim Khatib, Amit Parizat, Jabour Halloun, et al.
Pageof 24